Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17489814rdf:typepubmed:Citationlld:pubmed
pubmed-article:17489814lifeskim:mentionsumls-concept:C1335837lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C1705603lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C1837330lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C1413181lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C1823927lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C2828924lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:17489814lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:17489814pubmed:issue5lld:pubmed
pubmed-article:17489814pubmed:dateCreated2007-5-10lld:pubmed
pubmed-article:17489814pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17489814pubmed:abstractTextA de novo 4.1-megabase microdeletion of chromosome 1p34.2p34.3 has been identified by array-based comparative genomic hybridization in a young male with severely delayed development, microcephaly, pronounced hypotonia, and facial dysmorphism. The deleted region encompasses 48 genes, among them the glucose transporter 1 (SLC2A1 or GLUT1) gene. The deletion of the GLUT1 gene was in line with the abnormal ratio of cerebrospinal fluid (CSF) glucose to blood glucose, indicative of GLUT1 deficiency syndrome (MIM #606777). GLUT1 deficiency syndrome is characterized by therapy-resistant infantile seizures, developmental delay, acquired microcephaly, spasticity, ataxia, and a low concentration of glucose in the CSF. It is known that a ketogenic diet can lead to better control of seizures. This case study shows that identifying a microdeletion as the cause of learning disability is not only important for genetic counselling but might also lead to therapeutic intervention.lld:pubmed
pubmed-article:17489814pubmed:languageenglld:pubmed
pubmed-article:17489814pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17489814pubmed:citationSubsetIMlld:pubmed
pubmed-article:17489814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17489814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17489814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17489814pubmed:statusMEDLINElld:pubmed
pubmed-article:17489814pubmed:monthMaylld:pubmed
pubmed-article:17489814pubmed:issn0012-1622lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:SistermansEri...lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:VisserGepkeGlld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:PfundtRolphRlld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:WillemsenMich...lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:VermeerSascha...lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:KoolenDavid...lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:BrackelHein...lld:pubmed
pubmed-article:17489814pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:17489814pubmed:issnTypePrintlld:pubmed
pubmed-article:17489814pubmed:volume49lld:pubmed
pubmed-article:17489814pubmed:ownerNLMlld:pubmed
pubmed-article:17489814pubmed:authorsCompleteYlld:pubmed
pubmed-article:17489814pubmed:pagination380-4lld:pubmed
pubmed-article:17489814pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:meshHeadingpubmed-meshheading:17489814...lld:pubmed
pubmed-article:17489814pubmed:year2007lld:pubmed
pubmed-article:17489814pubmed:articleTitleA novel microdeletion in 1(p34.2p34.3), involving the SLC2A1 (GLUT1) gene, and severe delayed development.lld:pubmed
pubmed-article:17489814pubmed:affiliationDepartment of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.lld:pubmed
pubmed-article:17489814pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17489814pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:17489814pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17489814lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17489814lld:pubmed